Ingredients for diabetes, including a combination of long-acting insulin analysis and a combination of long-acting insulin

摘要

The current invention refers to an integral part of diabetes prevention or treatment, including a hybrid action insulin analysis and a combination of long-term action insulin. More specifically, the combination of long-term movement analysis and hyperinsulinemic displacement inhibited the increased weight due to insulin intake, as well as the vomiting and nausea due to insulin insulin intake, and also reduced the required dose. Insulin was injected, which greatly improved compliance with pharmacists. Besides,The current invention is a pharmacological synthesis for reducing the side effects of insulin cells in diabetic patients, including a long-acting insulin analysis combination and a long-acting insulin comprehensive analysis combination, There is also a way to reduce the side effects of pancreatic cells in diabetic patients, including the stage of cell composition control. In particular, the current invention is characterized by the reduction of side effects, such as pancreatic cancer cell dysfunction related to the development of diabetes,Pancreatin B cell quality decline, fat or glucose poisoning